Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NowPatient vs Regenics

NowPatient
Graded #222

Higher grade

vs+1.5
Regenics
Graded #250

Lower grade

The verdict

NowPatient takes it — 65.5/100 to 64/100, but only just.

NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda. Regenics is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRegenics +19
35
54
Dose & formulationNowPatient +16
93
77
Clinical oversightNowPatient +12
86
74
Labs & monitoringNowPatient +1
54
53
FulfillmentNowPatient +4
70
66
Contract termsEven
55
55
NowPatient · left barRegenics · right bar

The numbers

MetricNowPatientRegenics
WeighScore65.5/10064/100
GradeCC
Scorecard rank#222#250
Semaglutide$1,349/mo (brand Wegovy)$199/mo (starting dose, compounded)
Tirzepatide$1,069/mo (brand Mounjaro, promotional rate)$279/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesInjection only
NowPatient

Graded #222 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)
Regenics

Graded #250 · C

Strengths

  • Hybrid model — in-office visits near Tarzana, CA plus national telemed
  • Physical address published with a Google Maps link
  • Phone support published — uncommon for DTC-only competitors
  • Office hours clearly stated
  • $139/mo first-month intro is competitive with the low end of the market

Where it loses points

  • 503A pharmacy partner not named
  • LegitScript certification not mentioned
  • Full states-served list not disclosed
  • 503A vs 503B designation not specified
  • FDA compounded-medication disclaimer not visible on the homepage

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard